IRTC(iRhythm Holdings, Inc.) · 财务报表

IRTC(iRhythm Holdings, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$322.82M$410.92M$492.68M$591.84M$747.14M
毛利润$213.57M$281.63M$331.81M$407.53M$527.25M
营业利润−$99.94M−$113.78M−$125.16M−$115.50M−$57.41M
净利润−$101.36M−$116.16M−$123.41M−$113.29M−$44.55M
经营现金流−$37.75M−$23.01M−$50.10M$3.39M$80.86M
自由现金流−$65.82M−$52.84M−$90.53M−$30.55M$34.52M
摊薄每股收益$-3.46$-3.88$-4.04$-3.63$-1.39

iRhythm Holdings, Inc. IRTC